Should you buy, sell or hold Maruti Suzuki, Dr Reddy’s, PVR, Voltas, IndusInd, other stocks now?

Which stocks to buy, hold or sell today? Top brokerages have a slew of stocks on their radar on March 15, from spaces ranging from automobiles to pharmaceuticals to financial services. Here's what they make of the likes of Maruti Suzuki, Dr Reddy’s Laboratories (DRL), PVR, Voltas, IndusInd Bank and M&M Finance.

Check out the full list of stocks to buy, sell or hold, including Maruti Suzuki, Dr Reddy's PVR and Voltas:

Maruti Suzuki shares

Citi maintains a ‘buy’ rating on auto major Maruti Suzuki with a target price of Rs 12,500 per share — implying upside potential of 46.8 per cent from Tuesday's closing price. With relatively lighter vehicles and a fair share of CNG models, Maruti Suzuki is well equipped for new CAFÉ and OBD II norms, according to the brokerage.

However, Citi adds that the possible introduction of the mandatory six-airbag norms could result in higher costs for the company.

Dr Reddy’s Labs (DRL) shares

Macquarie maintains an ‘outperform’ rating on Dr Reddy's Laboratories and raises its target price by Rs 335 to Rs 5,250 apiece.

The company’s action towards improving its efficiency has borne fruit, but the best is yet to come, according to the brokerage. The R&D strategy change and tailored strategies for each business segment should start to deliver results for the company, Macquarie adds.

PVR shares

With the completion of the PVR-Inox merger, the companies' synergies and expansion are in focus, says BofA Securities.

Voltas shares

Nomura maintains a ‘buy’ on Voltas with a target price of Rs 1,083 per share.

Voltas should be able to touch nine per cent growth on the margin front in the near term, according to the brokerage.    

Morgan Stanley on financial shares

The brokerage maintains an ‘overweight’ rating each on IndusInd Bank, AU Small Finance Bank and M&M Finance.  

Morgan Stanley expects IndusInd Bank's margin to remain rangebound at 4.2-4.3 per cent and credit costs to remain in the range of 110-130 basis points.  

AU Small Finance Bank’s balance sheet growth focus has shifted from asset-led to liability-led strategy, according to the brokerage.

Morgan Stanley on speciality retail shares

Morgan Stanley has initiated coverage on the speciality retail segment. 

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.